Context Therapeutics Inc. SEC filings CNTX
Context Therapeutics Inc. has 307 filings in SEC EDGAR's recent list, going back to Mar 19, 2021. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 5, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 5, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 12, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 5, 2026 | Aug 5, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Listing notice
|
Jul 31, 2026 | Jul 29, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 31, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 27, 2026 | — |
| 4 | Insider transaction | Jun 26, 2026 | Jun 24, 2026 |
| 4 | Insider transaction | Jun 26, 2026 | Jun 24, 2026 |
| 4 | Insider transaction | Jun 26, 2026 | Jun 24, 2026 |
| 4 | Insider transaction | Jun 26, 2026 | Jun 24, 2026 |
| 4 | Insider transaction | Jun 26, 2026 | Jun 24, 2026 |
| 4 | Insider transaction | Jun 26, 2026 | Jun 24, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 26, 2026 | Jun 24, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 15, 2026 | Jun 15, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
May 18, 2026 | May 14, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 14, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 12, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 8, 2026 | — |
| 10-Q | Quarterly report | May 6, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Other events
|
May 1, 2026 | Apr 30, 2026 |
| ARS | Annual report to shareholders | Apr 28, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 28, 2026 | — |
| DEF 14A | Proxy statement | Apr 28, 2026 | Apr 28, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 17, 2026 | Jun 24, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 2, 2026 | Apr 2, 2026 |
| S-8 | Employee stock plan registration | Mar 23, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 23, 2026 | Mar 23, 2026 |
| 10-K | Annual report | Mar 23, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Mar 13, 2026 | Mar 11, 2026 |
| 8-K |
Current report
Other events
|
Feb 27, 2026 | Feb 24, 2026 |
| 4 | Insider transaction | Feb 23, 2026 | Feb 19, 2026 |
| 4 | Insider transaction | Feb 23, 2026 | Feb 19, 2026 |
| 4 | Insider transaction | Feb 23, 2026 | Feb 19, 2026 |
| 4 | Insider transaction | Feb 23, 2026 | Feb 19, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 3, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 8, 2026 | Jan 8, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 5, 2025 | Nov 5, 2025 |
| 10-Q | Quarterly report | Nov 5, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Oct 24, 2025 | Oct 24, 2025 |
| 424B5 | Prospectus supplement | Oct 24, 2025 | — |
| 8-K |
Current report
Other events
|
Oct 20, 2025 | Oct 17, 2025 |
| 8-K |
Current report
Listing notice
|
Sep 2, 2025 | Aug 28, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| 10-Q | Quarterly report | Aug 6, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 12, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 12, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 10, 2025 | Jun 9, 2025 |
| 4 | Insider transaction | Jun 10, 2025 | Jun 6, 2025 |
| 4 | Insider transaction | Jun 10, 2025 | Jun 6, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 9, 2025 |
| 3 | Initial insider ownership | Jun 9, 2025 | Jun 9, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 2, 2025 | Jun 2, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 9, 2025 | — |
| 10-Q | Quarterly report | May 7, 2025 | Mar 31, 2025 |
| ARS | Annual report to shareholders | Apr 15, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 15, 2025 | — |
| DEF 14A | Proxy statement | Apr 15, 2025 | Jun 12, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 9, 2025 | Apr 9, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 4, 2025 | Jun 12, 2025 |
| S-8 | Employee stock plan registration | Mar 20, 2025 | — |
| 10-K | Annual report | Mar 20, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Listing notice
|
Feb 28, 2025 | Feb 27, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| 4 | Insider transaction | Feb 14, 2025 | Feb 13, 2025 |
| 4 | Insider transaction | Feb 14, 2025 | Feb 13, 2025 |
| 4 | Insider transaction | Feb 14, 2025 | Feb 13, 2025 |
| 4 | Insider transaction | Feb 14, 2025 | Feb 13, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 12, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 27, 2025 | — |
| 4 | Insider transaction | Jan 14, 2025 | Jan 13, 2025 |
| 3 | Initial insider ownership | Jan 14, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 14, 2025 | Jan 14, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 13, 2025 | Jan 10, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 8, 2025 | — |
| 8-K |
Current report
Other events
|
Dec 23, 2024 | Dec 23, 2024 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Dec 2, 2024 | Dec 2, 2024 |
| 424B5 | Prospectus supplement | Dec 2, 2024 | — |
| EFFECT | Filing | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| CORRESP | Letter to the SEC | Nov 12, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 12, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 6, 2024 | — |
| S-3 | Shelf registration | Nov 6, 2024 | — |
| 10-Q | Quarterly report | Nov 6, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Sep 23, 2024 | Sep 23, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Sep 17, 2024 | Sep 17, 2024 |
| 4 | Insider transaction | Sep 5, 2024 | Sep 4, 2024 |
| 3 | Initial insider ownership | Sep 5, 2024 | Sep 4, 2024 |
| 4 | Insider transaction | Sep 5, 2024 | Sep 4, 2024 |
| 3 | Initial insider ownership | Sep 5, 2024 | Sep 4, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 4, 2024 | Sep 4, 2024 |
| 10-Q | Quarterly report | Aug 7, 2024 | Jun 30, 2024 |
| 4 | Insider transaction | Aug 1, 2024 | Aug 1, 2024 |
| 3 | Initial insider ownership | Aug 1, 2024 | Aug 1, 2024 |
| DEFA14A | Additional proxy material | Jul 24, 2024 | — |
| DEF 14A | Proxy statement | Jul 24, 2024 | Sep 17, 2024 |
| PRE 14A | Preliminary proxy statement | Jul 12, 2024 | Sep 17, 2024 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jul 10, 2024 | Jul 9, 2024 |
| 4 | Insider transaction | Jun 14, 2024 | Jun 13, 2024 |
| 4 | Insider transaction | Jun 14, 2024 | Jun 13, 2024 |
| 4 | Insider transaction | Jun 14, 2024 | Jun 13, 2024 |
| 4 | Insider transaction | Jun 14, 2024 | Jun 13, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 14, 2024 | Jun 13, 2024 |
| SC 13G | Ownership over 5% (passive) | Jun 5, 2024 | — |
| EFFECT | Filing | May 31, 2024 | — |
| 424B3 | Prospectus | May 31, 2024 | — |
| CORRESP | Letter to the SEC | May 29, 2024 | — |
| UPLOAD | Letter from the SEC | May 29, 2024 | — |
| SC 13G | Ownership over 5% (passive) | May 24, 2024 | — |
| S-3 | Shelf registration | May 24, 2024 | — |
| D | Filing | May 16, 2024 | — |
| SC 13G | Ownership over 5% (passive) | May 13, 2024 | — |
| SC 13G | Ownership over 5% (passive) | May 10, 2024 | — |
| 10-Q | Quarterly report | May 8, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
May 2, 2024 | May 1, 2024 |
| ARS | Annual report to shareholders | Apr 26, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 26, 2024 | — |
| DEF 14A | Proxy statement | Apr 26, 2024 | Jun 13, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 1, 2024 | Apr 1, 2024 |
| 4 | Insider transaction | Mar 22, 2024 | Mar 21, 2024 |
| 4 | Insider transaction | Mar 22, 2024 | Mar 21, 2024 |
| 4 | Insider transaction | Mar 22, 2024 | Mar 21, 2024 |
| S-8 | Employee stock plan registration | Mar 21, 2024 | — |
| 10-K | Annual report | Mar 21, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Mar 21, 2024 | Mar 19, 2024 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Mar 6, 2024 | Feb 29, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 7, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Jan 5, 2024 | — |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 31, 2023 | Oct 31, 2023 |
| 10-Q | Quarterly report | Aug 9, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 7, 2023 | Aug 7, 2023 |
| 8-K |
Current report
Other events
|
Jun 20, 2023 | Jun 15, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 2, 2023 | May 31, 2023 |
| 4 | Insider transaction | May 31, 2023 | May 31, 2023 |
| 4 | Insider transaction | May 31, 2023 | May 31, 2023 |
| 4 | Insider transaction | May 31, 2023 | May 31, 2023 |
| 4 | Insider transaction | May 31, 2023 | May 31, 2023 |
| 10-Q | Quarterly report | May 10, 2023 | Mar 31, 2023 |
| DEFA14A | Additional proxy material | Apr 6, 2023 | — |
| DEF 14A | Proxy statement | Apr 6, 2023 | May 31, 2023 |
| PRE 14A | Preliminary proxy statement | Mar 27, 2023 | May 31, 2023 |
| S-8 | Employee stock plan registration | Mar 22, 2023 | — |
| 10-K | Annual report | Mar 22, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations, Exit or restructuring costs, Regulation FD disclosure
|
Mar 22, 2023 | Mar 17, 2023 |
| 4 | Insider transaction | Feb 21, 2023 | Feb 21, 2023 |
| 4 | Insider transaction | Feb 14, 2023 | Feb 13, 2023 |
| 4 | Insider transaction | Feb 14, 2023 | Feb 13, 2023 |
| 4 | Insider transaction | Feb 14, 2023 | Feb 13, 2023 |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2023 | — |
| 4 | Insider transaction | Feb 13, 2023 | Feb 13, 2023 |
| 4 | Insider transaction | Feb 6, 2023 | Feb 6, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 6, 2023 | Feb 6, 2023 |
| 4 | Insider transaction | Jan 30, 2023 | Jan 30, 2023 |
| 8-K |
Current report
Listing notice
|
Jan 27, 2023 | Jan 24, 2023 |
| 4 | Insider transaction | Jan 23, 2023 | Jan 23, 2023 |
| 4 | Insider transaction | Jan 18, 2023 | Jan 17, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 10, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 9, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 4, 2023 | Jan 4, 2023 |
| 4 | Insider transaction | Dec 19, 2022 | Dec 16, 2022 |
| 4 | Insider transaction | Dec 19, 2022 | Dec 16, 2022 |
| 4 | Insider transaction | Dec 12, 2022 | Dec 9, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 8, 2022 | Dec 7, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 1, 2022 | Nov 29, 2022 |
| EFFECT | Filing | Nov 16, 2022 | — |
| CORRESP | Letter to the SEC | Nov 14, 2022 | — |
| 424B3 | Prospectus | Nov 14, 2022 | — |
| UPLOAD | Letter from the SEC | Nov 14, 2022 | — |
| EFFECT | Filing | Nov 10, 2022 | — |
| POS AM | Filing | Nov 9, 2022 | — |
| S-3 | Shelf registration | Nov 9, 2022 | — |
| 424B3 | Prospectus | Nov 9, 2022 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 9, 2022 | Nov 9, 2022 |
| 10-Q | Quarterly report | Nov 9, 2022 | Sep 30, 2022 |
| SC 13G | Ownership over 5% (passive) | Oct 27, 2022 | — |
| 424B3 | Prospectus | Sep 27, 2022 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 27, 2022 | Sep 27, 2022 |
| 4 | Insider transaction | Aug 22, 2022 | Aug 19, 2022 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CNTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Philadelphia, PA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1842952
- Former names
- Context Therapeutics LLC (until May 3, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.